Gerbes A, Zoulim F, Tilg H, et al. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut 2018;67:380–388. doi: 10.1136/gutjnl-2017-315068.

Figures 1, 3 and 4 of the above paper were published without acknowledgement of the original source. The legends should include the following information:

Figure 1. Adapted from Kurmann A, Wanner B, Martens F et al. Hepatic steatosis is associated with surgical-site infection after hepatic and colorectal surgery. Surgery 2014;156:109–16. With permission from Elsevier.

Figure 3. Reused from Villanueva A. Rethinking future development of molecular therapies in hepatocellular carcinoma: a bottom-up approach. J Hepatol 2013;59:392–5. With permission from Elsevier.

Figure 4. Adapted from Duffy AG, Ulahannan SV, Makorova-Rusher O et al. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol 2017;66:545–551. With permission from Elsevier.

The publisher apologises for the omission.